NCI Precision Medicine Study Hones in on Cancer Remission
Researchers say a non-chemotherapy treatment is causing more cancer patients to experience full remission.
A recent National Cancer Institute study shows that a new targeted therapy can help prolong the time cancer patients are in remission. Called the ViPOR regimen, the non-chemotherapy treatment shrinks tumors of those who suffer from B-cell lymphoma.
Dr. Christopher Melani, associate research physician with the Lymphoid Malignancies Branch in the Center for Cancer Research at NCI, highlights the importance of combining five therapies and administering them during a fixed cycle to maximize drug synergy and make tumors disappear.
He also shares details about the second phase of the study that is expected to take place later this year as well as how precision medicine could potentially lead to a cure for all types of cancer.
-
Dr. Christopher Melani Associate Research Physician, Lymphoid Malignancies Branch, Center for Cancer Research NCI
-
EPA Evolves Cyber Defense Amid Rising Threats
David Travers highlighted the agency’s upgraded defenses, federal partnerships and grant initiatives to tackle threats to water infrastructure.
20m listen -
How Holistic IT Strategies Drive Mission Outcomes
Former GSA associate CIO Erika Dinnie shares lessons on holistic modernization and offers practical guidance for federal employees exploring private sector opportunities.
5m watch -
CIOs Leverage Cloud to Unify Behavioral Health Services
CIOs shared how standardized infrastructure and real-time data capabilities are improving patient tracking, reporting and operational efficiency.
3m read -
AI-Driven Modernization is Boosting Patient Satisfaction
UK public health leader says that AI and cloud tools can reshape patient interactions and back-office operations.
3m read
